What are some common side effects that may occur with sparsentane?

Sparsentan, as a drug that has shown significant efficacy in the treatment of primary immunoglobulinA nephropathy and hypertension, has brought hope to many patients. However, like many other medications, sparsentane may be associated with some side effects.

Peripheral edema is a relatively common side effect in patients taking sparsentane. This manifests as swelling in areas such as the hands, legs, ankles, and feet, which may cause some discomfort to the patient. In addition, hypotension is also one of the side effects to be concerned about when using sparsentane. Clinical trial data show that the incidence of hypotension is higher in patients treated with sparsentan than in patients treated with other drugs. This drop in blood pressure may sometimes be accompanied by symptoms of dizziness, affecting the patient's daily activities.

Hyperkalemia is another side effect worth noting. Sparsentan may cause increased potassium levels in the blood, which is particularly dangerous in people with pre-existing kidney function problems. Therefore, regular monitoring of serum potassium levels is critical during sparsentane use.

Anemia is also a possible side effect of sparsentan. This means patients have a lowered red blood cell count, which can lead to symptoms such as fatigue and shortness of breath. At the same time, acute kidney injury and elevated transaminase are also side effects that need to be alerted during sparsentan treatment. Acute kidney injury may manifest as a sudden decline in kidney function, while elevated transaminases may indicate abnormal liver function.

Overall, although sparsentane has shown significant efficacy in treating specific diseases, patients still need to pay close attention to these possible side effects during use. It is important to seek medical advice immediately and seek professional advice if any discomfort or abnormal reaction occurs. Through reasonable medication guidance and monitoring, the therapeutic effect of sparsentane can be maximized while ensuring patient safety.